Metabolic syndrome‐like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|115|5|736-743

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.115, Iss.5, 2015-05, pp. : 736-743

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: Results from the REDUCE study

By  

CANCER, Vol. 120, Iss. 2, 2014-01 ,pp. : 190-196

John Wiley & Sons Inc

Access to resources Recommend Favorite

Moreira DM, Nickel JC, Gerber L, Muller RL, Andriole GL, Castro‐Santamaria R and Freedland SJ. Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: Results from the REDUCE study. Cancer. 2014;120:190‐196.

By  

CANCER, Vol. 121, Iss. 23, 2015-12 ,pp. : 4271-4271

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chronic baseline prostate inflammation is associated with lower tumor volume in men with prostate cancer on repeat biopsy: Results from the REDUCE study

By  

THE PROSTATE, Vol. 75, Iss. 13, 2015-09 ,pp. : 1492-1498

John Wiley & Sons Inc

Access to resources Recommend Favorite

ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)

By  

THE PROSTATE, Vol. 270-4137, Iss. 15, 2015-11 ,pp. : 1677-1681

John Wiley & Sons Inc

Access to resources Recommend Favorite

ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)

By  

THE PROSTATE, Vol. 75, Iss. 15, 2015-11 ,pp. : 1677-1681

John Wiley & Sons Inc

Access to resources Recommend Favorite